Skip to main content

Table 5 Antibiotic susceptibilities of 32 MRSA isolates, stratified by CA-MRSA criteria

From: Clinical and microbiological characteristics of purulent and non-purulent cellulitis in hospitalized Taiwanese adults in the era of community-associated methicillin-resistant Staphylococcus aureus

Antibiotic

No. (%) of samples, by susceptibility

Epidemiological classification

CA-MRSA (n = 22)

Non CA-MRSA (n = 10)

P-value

Chloramphenicol (%)

12 (54.5)

7 (70)

0.467

Clindamycin (%)a

4 (19)

0 (0)

0.287

Erythromycin (%)

4 (18.2)

0 (0)

0.283

Minocycline (%)

20 (95.2)

8 (80)

0.237

Levofloxacin (%)

18 (81.8)

5 (50)

0.096

Rifampin (%)

22 (100)

8 (80)

0.091

TMP-SMX (%)

21 (95.5)

7 (70)

0.079

Vancomycin (%)

22 (100)

10 (100)

1.000

  1. Data are number (%) of patients, unless otherwise indicated
  2. TMP-SMX trimethoprim-sulfamethoxazole
  3. aSusceptibility to clindamycin was determined for 21 CA-MRSA isolates and nine non-CA-MRSA isolates. The D-test was performed to detect inducible clindamycin resistance for isolates found to be resistant to erythromycin, but susceptible to clindamycin